Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions
- PMID: 22149034
- DOI: 10.2217/fon.11.131
Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions
Abstract
Comparative effectiveness research aims to help clinicians, patients and policymakers make informed treatment decisions under real-world conditions. Prostate cancer patients have multiple treatment options, including active surveillance, androgen deprivation therapy, surgery and multiple modalities of radiation therapy. Technological innovations in radiation therapy for prostate cancer have been rapidly adopted into clinical practice despite relatively limited evidence for effectiveness showing the benefit for one modality over another. Comparative effectiveness research has become an essential component of prostate cancer research to help define the benefits, risks and effectiveness of the different radiation therapy modalities currently in use for prostate cancer treatment.
Similar articles
-
Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10).Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):788-94. doi: 10.1016/j.ijrobp.2005.03.010. Int J Radiat Oncol Biol Phys. 2005. PMID: 16109464 Clinical Trial.
-
Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin.J Urol. 2000 Apr;163(4):1178-82. J Urol. 2000. PMID: 10737490
-
Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1322-31. doi: 10.1016/j.ijrobp.2004.12.053. Int J Radiat Oncol Biol Phys. 2005. PMID: 16029788
-
Comparative effectiveness research in localized prostate cancer treatment.J Comp Eff Res. 2013 Nov;2(6):583-93. doi: 10.2217/cer.13.66. J Comp Eff Res. 2013. PMID: 24236797 Review.
-
Endocrine treatment of prostate cancer.J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. doi: 10.1016/j.jsbmb.2004.10.005. Epub 2004 Dec 31. J Steroid Biochem Mol Biol. 2004. PMID: 15663992 Review.
Cited by
-
Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification method.Cancer. 2012 Nov 15;118(22):5535-43. doi: 10.1002/cncr.27597. Epub 2012 Apr 27. Cancer. 2012. PMID: 22544661 Free PMC article.
-
Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer.Cancer Treat Rev. 2016 Jul;48:50-60. doi: 10.1016/j.ctrv.2016.06.006. Epub 2016 Jun 17. Cancer Treat Rev. 2016. PMID: 27347670 Free PMC article. Review.
-
Evolution of advanced technologies in prostate cancer radiotherapy.Nat Rev Urol. 2013 Oct;10(10):565-79. doi: 10.1038/nrurol.2013.185. Epub 2013 Sep 10. Nat Rev Urol. 2013. PMID: 24018567 Review.
-
A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer.Res Rep Urol. 2016 Aug 18;8:145-58. doi: 10.2147/RRU.S58262. eCollection 2016. Res Rep Urol. 2016. PMID: 27574585 Free PMC article. Review.
-
The evolution of brachytherapy for prostate cancer.Nat Rev Urol. 2017 Jun 30;14(7):415-439. doi: 10.1038/nrurol.2017.76. Nat Rev Urol. 2017. PMID: 28664931 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical